{"name":"Xiromed LLC","slug":"xiromed-llc","ticker":"","exchange":"","domain":"xiromedllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNekI1MzFranFBOTJjY29fYlFNWXI0ajV0YXRFejNPd3VDM2Ewa1J5dGNVQVdfcTFtQV8wQkNqRDJfZUNCOFlKX192Tk5oanZJMkVCZ25IYkl5TkxyRkFHTHFBdEVpRnFtUmpaWGFCc2pEcVdLS21TWGE5Z19tWWNzVG5Tamp4UnplUE1IRjByVTE1V05PNHV2ZQ?oc=5","date":"2023-09-19","type":"regulatory","source":"Yahoo Finance","summary":"IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film - Yahoo Finance","headline":"IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOa2s0V3NkNnRlZXIzSFdDaHYzMFFFTVJBV1FTazRpM3I5TjZ0dHQwX2tuMW9SX0pZNXRyVDNsUXNoWU51dzZoVWdDZGhpUnhPX2MyZHdvNC1YUllaMFN4QVlNSGFZTGM5TDZ0N29ZMkRJeXc5NWs0RHpTaWlNdko5SmhHTERKVjd4ZDNRallwd3I3WTEwLTREWG0tc1VTd2ZVMldQQWIyYkZQRV8wT1NUcjh3TlQzZ1k?oc=5","date":"2020-11-11","type":"regulatory","source":"Medical Professionals Reference","summary":"Generic Version of Oral Contraceptive Taytulla Gets Approval - MPR - Medical Professionals Reference","headline":"Generic Version of Oral Contraceptive Taytulla Gets Approval - MPR","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9WbEhmdFU1VFkwM0tMS2QyLWdDZmxDeFZfRkxQa1VIdmdxSHRvbkFpN19EdVdNbHF0VGQ0NC05ZTNqUFpfV2VhUWcwNXE5bDNzMTJF?oc=5","date":"2020-11-09","type":"patent","source":"FirstWord Pharma","summary":"Xiromed Launches Gemmily, First-to-Market Generic to Taytulla - FirstWord Pharma","headline":"Xiromed Launches Gemmily, First-to-Market Generic to Taytulla","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}